Mangoceuticals expands its men's health product line with compounded hair growth treatment 'grow' by mangorx

Dallas, tx / accesswire / november 16, 2023 / mangoceuticals, inc. (nasdaq:mgrx) ("mangorx" or the "company"), a company focused on developing, marketing, and selling a variety of men's health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction (ed) drug branded "mango," today announced the expansion of its men's health product line with the addition of its hair growth treatment, ‘ grow .' the custom compounded hair growth treatment combines four clinically proven hair growth products - minoxidil, finasteride, vitamin d3, and biotin - encapsulated in convenient chewable, mint-flavored tablets.
MGRX Ratings Summary
MGRX Quant Ranking